The global demand for Healthcare Associated Infections Treatment Market is presumed to reach the valuation of nearly USD XXX MN by 2026 from USD XXX MN in 2019 with a CAGR of X.XX% under the study period of 2020 - 2026.
Healthcare-associated infections (HAI) can be referred to as infections that are developed in hospitals, nursing homes, or other healthcare facilities during hospitalization or while receiving treatments. These infections do exist before hospital admission. Healthcare staff, nurses, patients, their relatives, and visitors are the most vulnerable people who can get affected by HAI. HAI is caused by pathogenic agents such as bacteria, viruses, and fungi. The typical HAI include pneumonia, urinary tract infection, bloodstream infections, surgical site infections, and gastrointestinal infections. HAI is described as an unnecessary burden and risk globally as a significant number of people are affected by HAI every year. The main reason for HAI is contaminated hospital equipment devices, transmission through infected people, and improper usage of antibiotics.
The treatment plan for HAI includes the use of antibiotics, antiviral and antifungal drugs, ventilators, and other therapies. The global market for HAI treatment is growing rapidly, owing to the increasing prevalence of HAI. The other factors that are contributing to the market are reduced immunity of the people, overcrowded hospitals, rapidly spreading contagious diseases, contaminated hospital devices, growing bacterial resistance to the routinely used antibiotics. During COVID-19, the global HAI treatment market is expected to increase, owing to rapidly spreading pandemic and overcrowded hospitals.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of healthcare associated infections treatment.
The entire healthcare associated infections treatment market has been sub-categorized into product, pathogens, treatment, type of infections, diagnostics test and end use. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Type of Infections
By Diagnostics Test
- Urinary Tract Infections
- Surgical Site Infections
- Hospital-Acquired Pneumonia
- Bloodstream Infections
- Gastrointestinal Infections
- Respiratory Infections
- Other Healthcare-Associated Infections
By End Use
- Traditional Diagnostics
- Molecular Diagnostics
This section covers regional segmentation which accentuates on current and future demand for healthcare associated infections treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Europe Healthcare Associated Infections Treatment Market By Revenue (USD MN)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the healthcare associated infections treatment market include HORIBA, Ltd., BD., bioMérieux, Danaher, F. Hoffmann-La Roche Ltd, Meridian Bioscience, QIAGEN, ASP, Fortive, Johnson & Johnson Services, 3M, STERIS plc., Getinge AB., Cantel Medical., Belimed, Trinity Biotech, DiaSorin, OpGen, Accelerate Diagnostics, Thermo Fisher Scientific, Bio-Rad, Luminex Corporation., Quidel Corporation. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.